Igatan F
FDA Label NDC 72689-0027

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Oasis Trading for the product Igatan F (NDC 72689-0027). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, inactive ingredient, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Otc - Purpose

Preventing further damage to the gum tissue

Anti-inflammatory and Hemostatic action

Synergistic effect of periodontal disease treatment

Otc - Keep Out Of Reach Of Children

Keep out of reach of children

Indications & Usage

Adults: Take one capsule three times a day after meals.

Warnings

Please refer to the leaflet enclosed.

Inactive Ingredient

Corn starch, Lactose hydrate, Microcrystalline cellulose, Sodium starch glycolate, Colloidal silicon dioxide, Magnesium stearate, Capsule, Sunset yellow FCF, Quinoline yellow WS

Dosage & Administration

For oral use only

* Please review the disclaimer below.